Infection

Podcast: Preventing Lung Disease In Preterm Babies

Airway Therapeutics' surfactant protein D replacement therapy showed promising Phase Ib results in preventing bronchopulmonary dysplasia, now advancing to Phase II/III registration trial in preterm infants.

Topadur Sees Future Expansion From Wound Healing Into Longevity

A new CEO, a passionate founder, early-stage R&D and hopes of an IPO – can Swiss biotech Topadur find success?

EMA Focuses On Quality Criteria For Phage Therapy Approvals As Clinical Trials Grow

As trials of phage therapies for bacterial infections increase, the European Medicines Agency has proposed quality requirements in marketing applications for such products. Companies in this field include Locus Biosciences, Armata Pharmaceuticals, TechnoPhage, Phiogen, Medea Biopharma and BiomX.

A Race Against Time: Diagnostics Is Key To Tackling AMR

Charles Cooper, CMO of the diagnostics firm bioMérieux, talks to In Vivo about the vital nature of partnerships to fight the global AMR crisis.